Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2024 Oct 10.
Published in final edited form as: J Biol Inorg Chem. 2024 Aug 29;29(6):573–582. doi: 10.1007/s00775-024-02073-x

Antibacterial activity of Au(I), Pt(II), and Ir(III) biotin conjugates prepared by the iClick reaction: Influence of the metal coordination sphere on the biological activity

Dominik Moreth a, Lars Stevens-Cullinane b,c, Thomas W Rees b, Victoria VL Müller a, Adrien Pasquier d, Ok-Ryul Song d, Scott Warchal d, Michael Howell d, Jeannine Hess b,c, Ulrich Schatzschneider a,
PMCID: PMC7616682  EMSID: EMS199144  PMID: 39198276

Abstract

A series of biotin-functionalized transition metal complexes was prepared by iClick reaction from the corresponding azido complexes with a novel alkyne-functionalized biotin derivative ([Au(triazolatoR,R’)(PPh3)], [Pt(dpb)(triazolatoR,R’)], [Pt(triazolatoR,R’)(terpy)]PF6, and [Ir(ppy)(triazolatoR,R’)(terpy)]PF6 with dpb = 1,3-di(2-pyridyl)benzene, ppy = 2-phenylpyridine, and terpy = 2,2’:6’,2’’-terpyridine and R = C6H5, R’ = biotin). The complexes were compared to reference compounds lacking the biotin moiety. The binding affinity towards avidin and streptavidin was evaluated with the HABA assay as well as isothermal titration calorimetry (ITC). All compounds exhibit the same binding stoichiometry of complex-to-avidin of 4:1, but the ITC results show that the octahedral Ir(III) compound exhibits a higher binding affinity than the square planar Pt(II) complex. The antibacterial activity of the compounds was evaluated on a series of Gram-negative and Gram-positive bacterial strains. In particular, the neutral Au(I) and Pt(II) complexes showed significant antibacterial activity against Staphylococcus aureus and Enterococcus faecium at very low micromolar concentrations. The cytotoxicity against a range of eukaryotic cell lines was studied and revealed that the octahedral Ir(III) complex was non-toxic, while the square-planar Pt(II) and linear Au(I) complexes displayed non-selective micromolar activity.

Introduction

The steadily increasing emergence of drug-resistant bacterial strains requires novel approaches for antibacterial drug discovery [1, 2]. In recent years, there has been a surge in research directed at the identification of metal-based antibacterial drug candidates [38], a process which has been accelerated by the application of machine learning (ML) approaches to identify novel metal-ligand combinations overlooked so far by other approaches [9]. Although some large-scale screening efforts have determined the antibacterial potential of libraries composed of several hundred thousand metal complexes [7, 10], a systematic variation of metal and metal oxidation state, coordination sphere, and ligand periphery has rarely been carried out, with a good part of the available work focused on metal tricarbonyl complexes [7, 9, 1115]. A particularly interesting modification, which has seen only very limited exploration for antibacterial drug discovery so far, is the modification of metal complexes with biotin, a biological carrier molecule that is best known for its remarkable affinity to avidin, with an exceptionally high first dissociation constant (KD) of approximately 10-15 M, which has led to the widespread use of the biotin-avidin system in bioanalytical applications [1618]. Moreover, in vitro and in vivo studies indicate that the cellular uptake of biotin is facilitated by sodium-dependent multivitamin transporters (SMVTs), which are overexpressed for example in certain cancer cell lines [1921]. So far, biotin functionalization has mostly been used for cellular targeting of Re(I), Ru(II), Rh(III), and Ir(III) luminescent markers (Chart 1A) [2227]. In addition, heterobimetallic Fe(II)-Pt(II) compounds based on the combination of a ferrocene moiety with a square-planar Pt(alkynyl)(terpy) group with terpy = 2,2’:6’:2’’-terpyridine as well as BODIPY-Ru(terpy)2 conjugates have been investigated as potential photocytotoxic drug candidates (Chart 1B) [28, 29]. Furthermore, heteroleptic Ru(II) complexes with two unmodified 1,10-phenanthroline (phen) ligands and one biotin-functionalized phen were found to primarily accumulate in mitochondria [30]. Under 460 nm light irradiation, the complex generates reactive oxygen species (ROS) and deplete NADH, thus disrupting intracellular redox homeostasis in A549 cells and activating the mitochondrial apoptosis pathway. In vivo anti-tumor experiments demonstrated that biotinylated ruthenium(II) polypyridyl photosensitizers effectively inhibited tumor growth in A549 tumor-bearing mice under 460 nm light irradiation conditions. A biotin-functionalized 2,2’-bipyridine (bpy) ligand was also used by Garcia and Valente for conjugation to a CpRu(phosphane) half-sandwich fragment and the biological activity of the resulting compounds tested in vitro and in vivo, including zebrafish embryos [31]. On the other hand, there is only a very limited number of reports on the antibacterial activity of metal complex biotin conjugates. The first such report we could identify was published by Counter in 1960, who reported on the antimicrobial screening of a “copper complex of biotin” that was prepared by mixing of biotin and copper(II) sulfate under basic aqueous conditions [32]. With a sum formula of (C10H15N2O3S)3Cu2(H2O)4 proposed based on the elemental analysis, this is possibly some kind of dinuclear copper(II) paddlewheel complex [Cu2(µ-OOCR)3(H2O)4] [33], but in the absence of any further spectroscopic information, a proper structural assignment cannot be made and the antibacterial activity was only indicated by “zone of inhibition”. Only very recently, Valente and coworkers reported on Ru(II) arene half-sandwich complex with a pendant biotin group coordinated to the metal by a modified triphenylphosphine linker [34]. The type of linker between the phosphine moiety and the biotin was found to be crucial for significant antibacterial activity, with the most potent compound showing MIC values in the range of 1.5 to 12.5 µM on two different S. aureus strains but unfortunately differentiation between bacterial and eukaryotic cells was low, as the authors also found IC50 values on human cell lines in the range of 6–15 µM [34].

As highlighted by Frei, discovery of novel antibacterial metal-based drug candidates requires, beyond machine learning (ML) for the identification of novel promising substituent patterns on the ligands, a quick access to a large chemical space [9]. In that context, we have pioneered the use of the iClick (inorganic click) reaction of metal azido building blocks with functionalized alkynes [3542] and developed a method for automated iClick synthesis based on a re-purposed HPLC autosampler [43]. In this contribution, we present a novel synthetic approach to an alkyne-functionalized biotin via its Weinreb amide, the preparation of metal-triazolato complexes with different functionalities in the 4- and 5-position of the five-membered ring with variation of the metal coordination sphere from linear two-coordinated Au(I) and neutral as well as monocationic square-planar [3+1] Pt(II) complexes to octahedral [3+2+1] Ir(III) compounds and compare the biological activity of compounds featuring biotin groups or not.

Results and discussion

The alkyne-functionalized biotin derivative 5 was synthesized from the corresponding Weinreb amide 3 by reaction with lithium phenylacetylide in tetrahydrofuran at low temperature (Scheme 1 and Scheme S1+S2) [44]. The iClick reaction partners 69 were prepared by heating a solution of the corresponding metal chlorido complexes with an excess of sodium azide in a water/acetone mixture [41, 42, 45]. Neutral gold(I) azido complex 6 reacted smoothly with biotin alkyne 5 at room temperature over 24 h, while complete conversion of the platinum(II) azido complexes 6 and 7 as well as Ir(III) azido complex 8 required stirring at 80 °C for 3–5 d.

For comparison, the azido complexes 69 were also reacted with either 4-phenylbut-3-yn-2-one or dimethyl acetylenedicarboxylate (DMAD) to give triazolato compounds 11, 13, 15, and 17, in which the biotin moiety is replaced by a simple methyl group. All compounds were characterized by IR and NMR spectroscopy, mass spectrometry, and CHN analysis and found to be of the highest possible purity required for biological testing (Figure S1 to S34). For the triazolato complexes, 1H, 13C, 31P, and 195Pt NMR spectra show only one set of signals, indicating that only the N2-coordinated triazolato ligand is present in the complex, as previously reported [41, 42]. In the 31P NMR spectra of Au(I) complexes 11 and 12, there is a characteristic signal observed at 30.56 and 30.52 ppm, respectively, indicating the successful formation of the triazolato ring and its rearrangement to an exclusively N2-coordinated complex, as reported previously [45]. Similar, in the 1H NMR spectra of Pt(II) complexes 1316, there is a characteristic shift observed for the outer pyridine wing protons H6/H6’’ towards higher values upon triazolato ring formation. Additionally, the 195Pt NMR spectra show distinct differences in the chemical shifts of neutral Pt(II) dpb complexes 13 and 14 at -3661 [40] and -3686 ppm compared to the monocationic Pt(II) terpy complexes 15 and 16 with peaks at -2671 [42] and -2699 ppm, respectively. These results are in line with earlier studies on complexes 13 and 15, highlighting the crucial influence of the substituents in 4- and 5-position of the triazolato ring in determining the formation of the N2-coordinated heterocyclic ligand. Likewise, upon iClick reaction, the characteristic ppy-H6 signal shifts from 9.32 ppm in Ir(III) azido complex 9 to 8.88 ppm for triazolato compound 17, while in biotin-functionalized complex 18, the ppy-H6 is observed at 9.26 ppm, indicating a distinct chemical environment compared to 17 as previously reported [46].

Lipophilicity of the biotin complexes

As the lipophilicity of a compound significantly influences its cellular uptake and pharmacokinetic properties, the distribution coefficient logP was determined by the shake-flask method for organic biotin-alkyne 5 as well as metal complexes 1118 (Table 1) [47, 48]. The charged triazolato complexes 1518 are quite hydrophilic, with logP values in the range of 0.14 to –1.80, irrespective of the nature of the metal center – square planar Pt(II) vs. octahedral Ir(III). In the case of both metals, introduction of the biotin moiety to the periphery of the triazolato ligand led to an increase in the logP value by about one order of magnitude, thus making the biotin conjugates more lipophilic relative to the control compounds. Due to their low solubility and high lipophilicity, logP values could not be determined for neutral complexes 1114, as significant UV/Vis absorption was only observed in the n-octanol but not the aqueous phase. Consequently, a quantitative determination of logP values is not possible for these compounds.

Table 1.

LogP values of compounds 5 and 1118 determined with the shake-flask method.

Compound 11 12 13 14 15 16 17 18 5
Metal Au Au Pt Pt Pt Pt Ir Ir n/a
Charge 0 0 0 0 +1 +1 +1 +1 ---
Biotin - + - + - + - + +
LogP highly lipophilica highly lipophilica highly lipophilica highly lipophilica -1.80 -0.78 -1.02 0.14 highly lipophilica
a

No UV/Vis signal of the complexes was detectable in the aqueous phase; therefore, no concentration ratio could be calculated.

Avidin/streptavidin binding

The avidin binding of biotin-alkyne 5 as well as triazolato complexes 1118 was studied with the commercial HABA assay [16, 24]. Since the affinity of avidin for HABA (Kd = 6 × 10-6 M) is much lower than that for biotin (Kd = ~10-15 M), the competitive binding leads to displacement of HABA from the protein upon titration with biotin, resulting in a decrease in the absorbance at 500 nm. An example of these changes in the UV/Vis absorption spectrum are shown for the titration of a HABA/avidin mixture with the neutral biotin-functionalized Au(I) triazolato complex 12 (Figure 1 left). Similar changes were also observed for unmodified biotin, biotin-alkyne conjugate 5, and metal compounds 12, 14, 16, and 18. On the other hand, complexes 11, 13, 15, and 17 lacking the biotin moiety only showed signs of non-specific protein binding (Figure S35–S45). From a plot of the change in absorbance at 500 nm vs. the compound-to-avidin ratio, a clear 4:1 stoichiometry can be deduced, as expected due to the non-cooperative binding to avidin (Figure 1 right).

Figure 1.

Figure 1

(Left) Changes in the UV/Vis absorption spectrum upon titration of the HABA/avidin adduct with 12. (Right) -ΔAbs500nm vs. ratio of c(compound):c(avidin) for: biotin (black trace), [Au(PPh3)(triazolatoC6H5,biotin)] 12 (red trace), [Pt(dpb)(triazolatoC6H5,biotin)] 14 (blue trace), [Pt(triazolatoC6H5,biotin)(terpy)]PF6 16 (green trace), and [Ir(ppy)(triazolatoC6H5,biotin)(terpy)]PF6 18 (purple trace).

In addition, binding to the streptavidin monomer, which only features a single biotin binding site, was studied by isothermal titration calorimetry (ITC). Due to the low aqueous solubility of the neutral complexes in terms of the required biotin concentration, only the hydrophilic cationic Pt(II) and Ir(III) complexes 15, 16, and 18 could be investigated. Furthermore, due to a lower limit of the molar concentration that can be used in the assay, the dissociation constant of the functionalized biotin-alkyne 5 could only be estimated to be < 1 × 10-9 M. However, this value correlates well with literature data for unsubstituted biotin, which has a dissociation constant of 1.0 × 10-15 M [17]. The biotin-functionalized Ir(III) complex 18 exhibited a dissociation constant of (4.5 ± 1.8) × 10-8 M, whereas Pt(II) conjugate 16 binds less tightly, with Kd = (1.3 ± 0.4) × 10-7 M. In contrast, the non-functionalized Pt(II) complex 15 did not bind to streptavidin due to a lack of the biotin moiety, as expected (Figure S46–S49).

Cell viability and bacterial growth inhibition studies

The antibacterial activity of biotin-alkyne 5 as well as triazolato complexes 1118 was studied in Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecium, Staphylococcus aureus by a rapid screen broth microdilution assay (Figure S50 and S51). Activity was observed in E. faecium, and S. aureus and the minimum inhibitory concentrations (MICs) for these strains were determined with a MIC broth microdilution assay (Table 2). No significant antibacterial activity was observed in the Gram-negative bacterial strains for any of the tested compounds. However, neutral Au(I) complexes 11 and 12 as well as uncharged Pt(II) compound 14 showed MIC values in the 0.5–10 µM range in the Gram-positive E. faecium and S. aureus, irrespective of the presence of a biotin moiety. Generally, the Au(I) compounds appear to be slightly more potent than the Pt(II) compound, but differences are at the limit of the method. The charged complexes 1518 did not show any antibacterial effect, irrespective of metal coordination sphere and triazolato substituent pattern, while the lack of potency of neutral Pt(II) compound 13 currently cannot be rationalized, as it has a similar lipophilicity as the other three active complexes. The lack of susceptibility of the Gram-negative bacterial strains is typical due to their extensive defences. For example, the additional outer membrane in the Gram-negative cell wall which is difficult to penetrate for most compounds [49, 50].

Table 2.

Minimum inhibitory concentration (MIC) in μM for compounds 5 and 1118.

Compound 11 12 13 14 15 16 17 18 5 Control
Metal Au Au Pt Pt Pt Pt Ir Ir n/a n/a
Charge 0 0 0 0 +1 +1 +1 +1 0 n/a
Biotin - + - + - + - + + n/a
A. baumannii
(Gram negative)
100 50 >200 >200 >200 >200 >200 >200 >200 0.31a
E. coli
(Gram negative)
>200 >200 >200 >200 >200 >200 >200 >200 >200 12.5b
K. pnuemoniae
(Gram negative)
>200 >200 >200 >200 >200 >200 >200 >200 >200 <0.16a
P. aeruginosa
(Gram negative)
>200 >200 >200 >200 >200 >200 >200 >200 >200 100a
E. faecium
(Gram positive)
0.625–5 0.625–2.5 >200 5–10 >200 >200 >200 100 200 0.5c
S. aureus
(Gram positive)
2.5 1.25 200 12.5 >200 >200 >200 100 >200 12.5b
a

Ciprofloxacin

b

Carbenicillin

c

Vancomycin

The data for the Gram-negative bacterial strains is from a rapid screen without replicates while exact MIC values were from a broth microdilution assay.

To further evaluate the potential cytotoxicity of the title compounds, their antiproliferative activity was tested against non-malignant BEASB2 (non-cancer lung), HaCat (non-cancer skin), and RPE1 (retinal pigment epithelial cells) as well as cancerous HCT116 (colorectal cancer) and HeLa (cervical cancer) cell lines (Table 3). To determine the relative viability, after incubation cells were fixed and stained with DAPI and the number of nuclei per well determined using a CeligoTM Image Cytometer (Figure S52 to S60). Generally, there was little differentiation between cell lines for a single compound, as they were mostly either responsive (IC50 < 15 µM) or essentially non-cytotoxic (IC50 > 50 µM). The two Au(I) compounds 11 and 12 turned out to be highly toxic to all cell lines studied, with IC50 values in the range of 2–8 µM, irrespective of the presence of the biotin moiety. The neutral Pt(II) compound 13, with the two methyl ester substituents on the triazolato ligand, did not show any biological activity. This is interestingly also reflected in the antibacterial activity. The other three Pt(II) complexes (14–16) mostly showed moderate cytotoxicity, with IC50 values in the range of 5–15 µM, except against BEAS2B cells, which did not respond to 15 even at 50 µM. The two Ir(III) complexes 17 and 18, although also bearing a positive charge, were essentially inactive, with IC50 values consistently above 35 µM, irrespective of the functional groups on the triazolato ligand. The alkyne-functionalized biotin 5, on the other hand, turned out to be highly cytotoxic, with IC50 values in a narrow range of 2–4 µM, depending on the cell line. However, the compounds 13, 17, and 18 which are the least cytotoxic on eukaryotic cells are also the ones which do not exhibit any antimicrobial activity (Table 2), while complexes 11 and 12 with low to sub-micromolar MIC values are also highly cytotoxic in all five eukaryotic cell lines tested.

Table 3.

IC50 values for 5 and 1118 in µM determined after 48 h.

Compound 11 12 13 14 15 16 17 18 5
Metal Au Au Pt Pt Pt Pt Ir Ir n/a
Charge 0 0 0 0 +1 +1 +1 +1 0
Biotin functionalization - + - + - + - + +
BEAS2B 2.5 2.7 >50 6.7 >50 8.3 >50 >50 3.6
HACAT 6.1 6.6 >50 10.2 15.4 14.1 >50 >50 3.3
RPE1 2.7 3.6 >50 7.4 4.9 5.2 35.0 39.7 2.4
HCT116 5.5 7.2 >50 9.4 6.0 6.8 >50 >50 4.0
HeLa 3.5 3.8 >50 8.2 15.9 13.3 >50 >50 3.3

Conclusion

A series of biotin-functionalized metal triazolato complexes, including linear Au(I), square-planar Pt(II), and octahedral Ir(III) complexes was prepared by iClick reaction from the corresponding azido compounds and different internal alkynes. Among the Pt(II) compounds, a neutral vs. cationic charge was adjusted by use of a 1,3-di(2-pyridyl)phenide (dpb) vs. 2,2’:6’,2’’-terpyridine (terpy) tridentate ligand. While the Au(I) azido starting compound underwent smooth iClick reaction at room temperature with the new biotin-alkyne, the Pt(II) and Ir(III) precursors required extended heating, although the biotin moiety was not affected by the rather high reaction temperature. The avidin/streptavidin binding of the title compounds was compared to those lacking the biotin moiety using the HABA assay as well as isothermal titration calorimetry (ITC) and was not influenced by the presence of the metal moiety. Although a lack of differentiation between bacterial and eukaryotic cell lines was observed, some important conclusions can still be drawn from the bioactivity data on general structure-activity relationships. First, the biotin substituent increases the lipophilicity of the conjugates by about one order of magnitude but does not have a significant influence on the biological activity, as no effect is seen on neither MIC nor IC50 values. Second, the linear Au(I) compounds are highly active, at times with sub-micromolar MIC values, but their activity is quite non-specific, as they are toxic on both bacterial and eucaryotic cells. The octahedral Ir(III) complexes, on the other hand, lack any biological activity but might be useful as luminescent probes [46]. Finally, the square-planar Pt(II) complexes are intermediate between the two other classes of compounds and their antibacterial vs. anticancer activity seems to be controlled by a fine balance of charge and triazolato substitution pattern, which will require further examination to work out clear trends.

Supplementary Material

Figure S1

Figure 2. (Top) Unprocessed ITC thermogram and (bottom) binding isotherm from the integrated thermogram fit for the binding of Ir(III) compound 18 (200 µM) to streptavidin (20 µM).

Figure 2

Circles indicate the integrated heat, and the curve represents the best fit.

Chart 1:

Chart 1:

Examples of biotin-functionalized metal complexes for (A) bioimaging and (B) anticancer and antibacterial activity.

Scheme 1:

Scheme 1:

(Top) Synthesis of biotin alkyne 5 from the corresponding Weinreb amide 3. (Bottom) iClick reaction of azido complexes 69 with electron-poor alkynes leads to triazolato complexes 1118.

Acknowledgements

We would like to thank Simone Kunzelmann and Laura Masino from the Structural Biology (STP) unit at the Francis Crick Institute for assisting with the ITC measurements and training.

Funding

J.H., T.W.R., and L.S.C. are supported by the Francis Crick Institute, which receives its core funding from Cancer Research U.K. (CC2215), the United Kingdom Medical Research Council (CC2215), the Wellcome Trust (CC2215), and KCL.

List of abbreviations

BODIPY

4,4-difluoro-4-bora-3a,4a-diaza-s-indacen

bpy

2,2’-bipyridine

DAPI

4′,6-diamidino-2-phenylindole

DMAD

dimethyl acetylenedicarboxylate

dpb

1,3-di(2-pyridyl)benzene

HABA

4’-hydroxyazobenzol-2-carboxylic acid

IR

infrared

ITC

isothermal titration calorimetry

MIC

minimum inhibitory concentration

NADH

nicotinamide adenine dinucleotide

NMR

nuclear magnetic resonance

ppy

2-phenylpyridine

ROS

reactive oxygen species

SMVT

sodium-dependent multivitamin transporters

terpy

2,2’:6’,2’’-terpyridine

UV/Vis

ultraviolet/visible

Footnotes

Author contributions

The metal complex synthesis and characterization was done by D.M., except for the gold compounds, which were prepared by V.M. The logP determinations and HABA/Avidin assay was performed by D.M. The isothermal titration calorimetry (ITC) was done by L.S.C. Bacterial inhibition assays were performed by T.W.R. Human cell culture was performed by A.P., O.-R. S., and M.H. The script used to determine IC50 values was written by S.W. The manuscript was written by D.M., J.H., and U.S. with input from all authors.

Conflict of interest

There are no conflicts to declare.

Availability of data and materials

All data relevant to this publication is included in the manuscript or the supporting information.

References

  • 1.Lakemeyer M, Zhao W, Mandl FA, Hammann P, Sieber SA. Thinking outside the box - novel antibacterials to tackle the resistance crisis. Angew Chem Int Ed. 2018;57:14440–14475. doi: 10.1002/anie.201804971. [DOI] [PubMed] [Google Scholar]
  • 2.Cole ST. Who will develop new antibacterial agents? Philosophical Transactions of the Royal Society B. 2014;369:2013043. doi: 10.1098/rstb.2013.0430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schatzschneider U. In: Advances in bioorganometallic chemistry. Hirao T, Moriuchi T, editors. Elsevier; Amsterdam: 2018. [Google Scholar]
  • 4.Kljun J, Bratsos I, Alessio E, Psomas G, Repnik U, Butinar M, Turk B, Turel I. New uses for old drugs: Attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium. Inorg Chem. 2013;52:9039–9052. doi: 10.1021/ic401220x. [DOI] [PubMed] [Google Scholar]
  • 5.Li F, Collins JG, Keene FR. Ruthenium complexes as antimicrobial agents. Chem Soc Rev. 2015;44:2529–2542. doi: 10.1039/c4cs00343h. [DOI] [PubMed] [Google Scholar]
  • 6.Patra M, Gasser G, Metzler-Nolte N. Small organometallic compounds as antibacterial agents. Dalton Trans. 2012;41:6350–6358. doi: 10.1039/c2dt12460b. [DOI] [PubMed] [Google Scholar]
  • 7.Frei A, Zuegg J, Elliott AG, Baker M, Bräse S, Brown C, Chen F, Dowson CG, Dujardin G, Jung N, King AP, et al. Metal complexes as a promising source for new antibiotics. Chem Sci. 2020;11:2627–2639. doi: 10.1039/c9sc06460e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MAT. Metals to combat antimicrobial resistance. Nature Reviews Chemistry. 2023;7:202–224. doi: 10.1038/s41570-023-00463-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Scaccaglia M, Birbaumer MP, Pinelli S, Pelosi G, Frei A. Discovery of antibacterial manganese(i) tricarbonyl complexes through combinatorial chemistry. Chem Sci. 2024;15:3907–3919. doi: 10.1039/d3sc05326a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Weng C, Yang H, Loh BS, Wong MW, Ang WH. Targeting pathogenic formate-dependent bacteria with a bioinspired metallo-nitroreductase complex. J Am Chem Soc. 2023;145:6453–6461. doi: 10.1021/jacs.3c00237. [DOI] [PubMed] [Google Scholar]
  • 11.Glans L, Hu W, de Kock C, Smith PJ, Haukka M, Bruhn H, Schatzschneider U, Nordlander E. Synthesis and biological activity of cymantrene and cyrhetrene 4-aminoquinoline conjugates against malaria, leishmaniasis, and trypanosomiasis. Dalton Trans. 2012;41:6443–6450. doi: 10.1039/c2dt30077j. [DOI] [PubMed] [Google Scholar]
  • 12.Simpson PV, Nagel C, Bruhn H, Schatzschneider U. Antibacterial and antiparasitic activity of manganese(i) tricarbonyl complexes with ketoconazole, miconazole, and clotrimazole ligands. Organometallics. 2015;34:3809–3815. doi: 10.1021/acs.organomet.5b00458. [DOI] [Google Scholar]
  • 13.Tinajero-Trejo M, Rana N, Nagel C, Jesse HE, Smith TW, Wareham LK, Hippler M, Schatzschneider U, Poole RK. Antimicrobial activity of the manganese photoactivated carbon monoxide-releasing molecule [mn(co)3(tpa-κ3n)]+ against a pathogenic escherichia coli that causes urinary infections. Antioxid Redox Signal. 2016;24:765–780. doi: 10.1089/ars.2015.6484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Güntzel P, Nagel C, Weigelt J, Betts JW, Pattrick CA, Southam HM, La Ragione RM, Poole RK, Schatzschneider U. Biological activity of manganese(i) tricarbonyl complexes on multidrugresistant gram-negative bacteria: From functional studies to in vivo activity in galleria mellonella. Metallomics. 2019;11:2033–2042. doi: 10.1039/c9mt00224c. [DOI] [PubMed] [Google Scholar]
  • 15.Betts JW, Roth P, Pattrick CA, Southam HM, La Ragione RM, Poole RK, Schatzschneider U. Antibacterial activity of mn(i) and re(i) tricarbonyl complexes conjugated to a bile acid carrier molecule. Metallomics. 2020;12:1563–1575. doi: 10.1039/d0mt00142b. [DOI] [PubMed] [Google Scholar]
  • 16.Green NM. In: Advances in protein chemistry. Anfinsen CB, Edsall JT, Richards FM, editors. Academic Press; 1975. pp. 85–133. [DOI] [PubMed] [Google Scholar]
  • 17.Michael Green N. In: Methods in enzymology. Wilchek M, Bayer EA, editors. Academic Press; 1990. pp. 51–67. [Google Scholar]
  • 18.Wilchek M, Bayer EA. In: Methods in enzymology. Wilchek M, Bayer EA, editors. Academic Press; 1990. pp. 5–13. [DOI] [PubMed] [Google Scholar]
  • 19.Tripodo G, Mandracchia D, Collina S, Rui M, Rossi D. New perspectives in cancer therapy: The biotin-antitumor molecule conjugates. Med Chem. 2014;8:1–4. [Google Scholar]
  • 20.Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Functional and molecular aspects of biotin uptake via smvt in human corneal epithelial (hcec) and retinal pigment epithelial (d407) cells. The AAPS journal. 2012;14:832–842. doi: 10.1208/s12248-012-9399-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dutt Vadlapudi A, Krishna Vadlapatla R, Mitra KA. Sodium dependent multivitamin transporter (smvt): A potential target for drug delivery. Current drug targets. 2012;13:994–1003. doi: 10.2174/138945012800675650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lo KK-W, Hui W-K, Ng DC-M. Novel rhenium(i) polypyridine biotin complexes that show luminescence enhancement and lifetime elongation upon binding to avidin. J Am Chem Soc. 2002;124:9344–9345. doi: 10.1021/ja026598n. [DOI] [PubMed] [Google Scholar]
  • 23.Lo KK-W, Lee TK-M. Luminescent ruthenium(ii) polypyridine biotin complexes: Synthesis, characterization, photophysical and electrochemical properties, and avidin-binding studies. Inorg Chem. 2004;43:5275–5282. doi: 10.1021/ic049750q. [DOI] [PubMed] [Google Scholar]
  • 24.Lo KK-W, Chan JS-W, Lui L-H, Chung C-K. Novel luminescent cyclometalated iridium(iii) diimine complexes that contain a biotin moiety. Organometallics. 2004;23:3108–3116. doi: 10.1021/om0499355. [DOI] [Google Scholar]
  • 25.Lo KK-W, Hui W-K. Design of rhenium(i) polypyridine biotin complexes as a new class of luminescent probes for avidin. Inorg Chem. 2005;44:1992–2002. doi: 10.1021/ic049059n. [DOI] [PubMed] [Google Scholar]
  • 26.Leung S-K, Kwok KY, Zhang KY, Lo KK-W. Design of luminescent biotinylation reagents derived from cyclometalated iridium(iii) and rhodium(iii) bis(pyridylbenzaldehyde) complexes. Inorg Chem. 2010;49:4984–4995. doi: 10.1021/ic100092d. [DOI] [PubMed] [Google Scholar]
  • 27.Li J, Zeng L, Xiong K, Rees TW, Jin C, Wu W, Chen Y, Ji L, Chao H. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy. Chem Commun. 2019;55:10972–10975. doi: 10.1039/c9cc05826e. [DOI] [PubMed] [Google Scholar]
  • 28.Mitra K, Shettar A, Kondaiah P, Chakravarty AR. Biotinylated platinum(ii) ferrocenylterpyridine complexes for targeted photoinduced cytotoxicity. Inorg Chem. 2016;55:5612–5622. doi: 10.1021/acs.inorgchem.6b00680. [DOI] [PubMed] [Google Scholar]
  • 29.Paul S, Sahoo S, Sahoo S, Jayabaskaran C, Chakravarty AR. Bichromophoric bodipy and biotin tagged terpyridyl ruthenium(ii) complexes for cellular imaging and photodynamic therapy. Eur J Inorg Chem. 2022;2022:e202200487. doi: 10.1002/ejic.202200487. [DOI] [Google Scholar]
  • 30.Wei L, He X, Zhao D, Kandawa-Shultz M, Shao G, Wang Y. Biotin-conjugated ru(ii) complexes with aie characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance. European Journal of Medicinal Chemistry. 2024;264:115985. doi: 10.1016/j.ejmech.2023.115985. [DOI] [PubMed] [Google Scholar]
  • 31.Côrte-Real L, Karas B, Brás AR, Pilon A, Avecilla F, Marques F, Preto A, Buckley BT, Cooper KR, Doherty C, Garcia MH, et al. Ruthenium-cyclopentadienyl bipyridine-biotin based compounds: Synthesis and biological effect. Inorg Chem. 2019;58:9135–9149. doi: 10.1021/acs.inorgchem.9b00735. [DOI] [PubMed] [Google Scholar]
  • 32.Counter FT, Duvall RN, Foye WO, Vanderwyk RW. The preparation and antibacterial action of metal chelates of some antitubercular agents, amino acids, and peptides. J Am Pharm Assoc. 1960;49:140–143. doi: 10.1002/jps.3030490305. [DOI] [PubMed] [Google Scholar]
  • 33.Schatzschneider U, Weyhermüller T, Rentschler E. Copper complexes with mono- and bidentate-bridging nitronyl nitroxide-substituted benzoate ligands. Inorg Chim Acta. 2002;337:122–130. doi: 10.1016/S0020-1693(02)01103-9. [DOI] [Google Scholar]
  • 34.Teixeira RG, Mészáros JP, Matos B, Côrte-Real L, Xavier CPR, Fontrodona X, Garcia MH, Romero I, Spengler G, Vasconcelos MH, Tomaz AI, et al. Novel family of [rucp(n,n)(p)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies. European Journal of Medicinal Chemistry. 2023;262:115922. doi: 10.1016/j.ejmech.2023.115922. [DOI] [PubMed] [Google Scholar]
  • 35.Henry L, Schneider C, Mützel B, Simpson PV, Nagel C, Fucke K, Schatzschneider U. Amino acid bioconjugation via iclick reaction of an oxanorbornadiene-masked alkyne with a mni(bpy)(co)3-coordinated azide. Chem Commun. 2014;50:15692–15695. doi: 10.1039/c4cc07892f. [DOI] [PubMed] [Google Scholar]
  • 36.Schmid P, Maier M, Pfeiffer H, Belz A, Henry L, Friedrich A, Schönfeld F, Edkins K, Schatzschneider U. Catalyst-free room-temperature iclick reaction of molybdenum(ii) and tungsten(ii) azide complexes with electron-poor alkynes: Structural preferences and kinetic studies. Dalton Trans. 2017;46:13386–13396. doi: 10.1039/c7dt03096g. [DOI] [PubMed] [Google Scholar]
  • 37.Waag-Hiersch L, Mößeler J, Schatzschneider U. Electronic influences on the stability and kinetics of cp* rhodium(iii) azide complexes in the iclick reaction with electron-poor alkynes. Eur J Inorg Chem. 2017 doi: 10.1002/ejic.201700199. doi: 10.1002/ejic.201700199. [DOI] [Google Scholar]
  • 38.Peng K, Mawamba V, Schulz E, Löhr M, Hagemann C, Schatzschneider U. Iclick reactions of square-planar palladium(ii) and platinum(ii) azido complexes with electron-poor alkynes: Metal-dependent preference for n1 vs. N2 triazolate coordination and kinetic studies with 1h and 19f nmr spectroscopy. Inorg Chem. 2019;58:11508–11521. doi: 10.1021/acs.inorgchem.9b01304. [DOI] [PubMed] [Google Scholar]
  • 39.Peng K, Einsele R, Irmler P, Winter RF, Schatzschneider U. The iclick reaction of a bodipy platinum(ii) azido complex with electron-poor alkynes provides triazolate complexes with good 1o2 sensitization efficiency. Organometallics. 2020;39:1423–1430. doi: 10.1021/acs.organomet.0c00128. [DOI] [Google Scholar]
  • 40.Peng K, Moreth D, Schatzschneider U. C^n^n coordination accelerates the iclick reaction of square-planar palladium(ii) and platinum(ii) azido complexes with electron-poor alkynes and enables cycloaddition with terminal alkynes. Organometallics. 2021;40:2584–2593. doi: 10.1021/acs.organomet.1c00293. [DOI] [Google Scholar]
  • 41.Moreth D, Hörner G, Müller VVL, Geyer L, Schatzschneider U. Isostructural series of ni(ii), pd(ii), pt(ii), and au(iii) azido complexes with a n^c^n pincer ligand to elucidate trends in the iclick reaction kinetics and structural parameters of the triazolato products. Inorg Chem. 2023;62:16000–16012. doi: 10.1021/acs.inorgchem.3c02122. [DOI] [PubMed] [Google Scholar]
  • 42.Müller VVL, Simpson PV, Peng K, Basu U, Moreth D, Nagel C, Türck S, Oehninger L, Ott I, Schatzschneider U. Taming the biological activity of pd(ii) and pt(ii) complexes with triazolato “protective” groups: 1h, 77se nuclear magnetic resonance and x-ray crystallographic model studies with selenocysteine to elucidate differential thioredoxin reductase inhibition. Inorg Chem. 2023;62:16203–16214. doi: 10.1021/acs.inorgchem.3c02701. [DOI] [PubMed] [Google Scholar]
  • 43.Zach T, Geyer F, Kiendl B, Mößeler J, Nguyen O, Schmidpeter T, Schuster P, Nagel C, Schatzschneider U. Electrospray mass spectrometry to study combinatorial iclick reactions and multiplexed kinetics of [ru(n3)(n∧n)(terpy)]pf6 with alkynes of different steric and electronic demand. Inorg Chem. 2023;62:2982–2993. doi: 10.1021/acs.inorgchem.2c03377. [DOI] [PubMed] [Google Scholar]
  • 44.Nahm S, Weinreb SM. N-methoxy-n-methylamides as effective acylating agents. Tetrahedron Lett. 1981;22:3815–3818. doi: 10.1016/S0040-4039(01)91316-4. [DOI] [Google Scholar]
  • 45.Del Castillo TJ, Sarkar S, Abboud KA, Veige AS. 1,3-dipolar cycloaddition between a metal-azide (ph3paun3) and a metal acetylide (ph3pauccph): An inorganic version of a click reaction. Dalton Trans. 2011;40:8140–8144. doi: 10.1039/c1dt10787a. [DOI] [PubMed] [Google Scholar]
  • 46.Müller VVL, Moreth D, Kowalski K, Kowalczyk A, Gapińska M, Kutta RJ, Nuernberger P, Schatzschneider U. Tuning the intracellular distribution of [3+2+1] iridium(iii) complexes in bacterial and mammalian cells by iclick reaction with biomolecular carriers functionalized with alkynone groups. Chem Eur J. 2024 doi: 10.1002/chem.202401603. in print. [DOI] [PubMed] [Google Scholar]
  • 47.Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev. 1971;71:525–616. [Google Scholar]
  • 48.Simpson PV, Schmidt C, Ott I, Bruhn H, Schatzschneider U. Synthesis, cellular uptake and biological activity against pathogenic microorganisms and cancer cells of rhodium and iridium n-heterocyclic carbene complexes bearing charged substituents. Eur J Inorg Chem. 2013;2013:5547–5554. doi: 10.1002/ejic.201300820. [DOI] [Google Scholar]
  • 49.Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, Honrao C, et al. A new antibiotic selectively kills gram-negative pathogens. Nature. 2019;576:459–464. doi: 10.1038/s41586-019-1791-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhao S, Adamiak JW, Bonifay V, Mehla J, Zgurskaya HI, Tan DS. Defining new chemical space for drug penetration into gram-negative bacteria. Nature Chemical Biology. 2020;16:1293–1302. doi: 10.1038/s41589-020-00674-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1

Data Availability Statement

All data relevant to this publication is included in the manuscript or the supporting information.

RESOURCES